AEON Biopharma Inc. (AEON) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AEON Biopharma Inc.

    NASDAQ: AEON · Real-Time Price · USD
    0.73
    -0.03 (-4.34%)
    At close: Sep 08, 2025, 3:52 PM
    0.73
    0.03%
    After-hours: Sep 08, 2025, 04:29 PM EDT

    AEON Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 72.98M n/a -48.43M -65.85M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 42.01M n/a -52.56M -55.64M
    Net Income
    		 42.01M n/a -52.56M -55.64M
    Selling & General & Admin
    		 13.64M n/a 13.68M 11.15M
    Research & Development
    		 14.18M n/a 34.75M 25.73M
    Other Expenses
    		 -100.81M n/a n/a 28.97M
    Operating Expenses
    		 -72.98M n/a 48.43M 65.85M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -72.98M n/a 48.43M 65.85M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 7.5K 516.11K 305.5K 305.5K
    Shares Outstanding (Diluted)
    		 8K 516.11K 305.5K 305.5K
    EPS (Basic)
    		 5.6K n/a -172.03 -182.12
    EPS (Diluted)
    		 5.25K n/a -172.03 -182.12
    EBITDA
    		 -27.73M n/a -48.36M -36.88M
    EBIT
    		 -27.82M n/a -48.43M -36.88M
    Depreciation & Amortization
    		 97K n/a 68K 3K

    Add to Watchlist